Nouvelles approches thérapeutiques dans les stades IV de cancers bronchiques non à petites cellules (CBNPC)MAVROUDIS, D.Revue de pneumologie clinique (Paris). 2001, Vol 57, Num 5, pp 2S42-2S45, issn 0761-8417, 2Conference Paper

Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss historyGIOULBASANIS, I; BARACOS, V. E; GIANNOUSI, Z et al.Annals of oncology. 2011, Vol 22, Num 4, pp 835-841, issn 0923-7534, 7 p.Article

Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancerMAVROUDIS, D; PAPAKOTOULAS, P; KENTEPOZIDIS, N et al.Annals of oncology. 2010, Vol 21, Num 1, pp 48-54, issn 0923-7534, 7 p.Article

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLCKALIKAKI, A; KOUTSOPOULOS, A; TRYPAKI, M et al.British journal of cancer. 2008, Vol 99, Num 6, pp 923-929, issn 0007-0920, 7 p.Article

Dose escalation study on oxaliplatin and Capecitabine (Xeloda) in patients with advanced solid tumorsKAKOLYRIS, S; SOUGLAKOS, J; GEORGOULIAS, V et al.Oncology. 2004, Vol 66, Num 4, pp 253-259, issn 0030-2414, 7 p.Article

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumoursANDROULAKIS, N; KOUROUSSIS, C; GEORGOULIAS, V et al.European journal of cancer (1990). 2002, Vol 38, Num 15, pp 1992-1997, issn 0959-8049Article

A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancerAGELAKI, S; KAKOLYRIS, S; PALAMIDAS, Ph et al.Lung cancer. 2001, Vol 34, Num 1, pp 133-139, issn 0169-5002Article

Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (cl) of 5-fluorouracil (5-Fu) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanesKALBAKIS, K; KOUROUSSIS, Ch; KAKOLYRIS, S et al.British journal of cancer. 2001, Vol 85, Num 6, pp 798-802, issn 0007-0920Article

Phase I study of the gemcitbine/oxaliplatin combination in patients with advanced solid tumors : A preliminary reportMAVROUDIS, D; KOUROUSIS, C; KAKOLYRIS, S et al.Seminars in oncology. 2000, Vol 27, Num 1, pp 25-30, issn 0093-7754, SUP2Article

Clinical challenges in the molecular characterization of circulating tumour cells in breast cancerLIANIDOU, E. S; MAVROUDIS, D; GEORGOULIAS, V et al.British journal of cancer. 2013, Vol 108, Num 12, pp 2426-2432, issn 0007-0920, 7 p.Article

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancerANDROULAKIS, N; AGELAKI, S; PERRAKI, M et al.British journal of cancer. 2012, Vol 106, Num 12, pp 1917-1925, issn 0007-0920, 9 p.Article

Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research GroupPALLIS, A. G; KARAMPEAZIS, A; VAMVAKAS, L et al.Annals of oncology. 2011, Vol 22, Num 11, pp 2448-2455, issn 0923-7534, 8 p.Article

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancerDASKALAKI, A; AGELAKI, S; PERRAKI, M et al.British journal of cancer. 2009, Vol 101, Num 4, pp 589-597, issn 0007-0920, 9 p.Article

Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancerKIOULAFA, M; KAKLAMANIS, L; STATHOPOULOS, E et al.Annals of oncology. 2009, Vol 20, Num 6, pp 1020-1025, issn 0923-7534, 6 p.Article

A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursBOZIONELOU, V; VAMVAKAS, L; GEORGOULIAS, V et al.British journal of cancer. 2007, Vol 97, Num 1, pp 43-49, issn 0007-0920, 7 p.Article

Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma : a multicenter phase II study of the Hellenic Oncology Research GroupBOUKOVINAS, I; ANDROULAKIS, N; MAVROUDIS, D et al.Annals of oncology. 2006, Vol 17, Num 11, pp 1687-1692, issn 0923-7534, 6 p.Article

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use programPALLIS, A. G; MAVROUDIS, D; ANDROULAKIS, N et al.Lung cancer. 2003, Vol 40, Num 3, pp 301-307, issn 0169-5002, 7 p.Article

Phase I study of Paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) administered every 2 weeks in patients with advanced solid tumorsMAVROUDIS, D; KOUROUSSIS, Ch; KAKOLYRIS, S et al.Oncology. 2002, Vol 62, Num 3, pp 216-222, issn 0030-2414Article

A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancerMAVROUDIS, D; PAPADAKIS, E; VLACHONICOLIS, J et al.Annals of oncology. 2001, Vol 12, Num 4, pp 463-470, issn 0923-7534Article

A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapyKAKOLYRIS, S; SOUGLAKOS, J; AGELAKI, S et al.Lung cancer. 2000, Vol 30, Num 3, pp 193-198, issn 0169-5002Article

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma : a multicentre phase I studyGIANNAKAKIS, T; ZIRAS, N; VLACHONIKOLIS, J et al.European journal of cancer (1990). 2000, Vol 36, Num 6, pp 742-747, issn 0959-8049Article

Alloreactive CD4⁺ T lymphocytes can exert cytotoxicity to chornic myeloid leukaemia cells processing and presenting exogenous antigenJIANG, Y.-Z; MAVROUDIS, D; DERMIME, S et al.British journal of haematology. 1996, Vol 93, Num 3, pp 606-612, issn 0007-1048Article

Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy : evaluation of their clinical relevanceAPOSTOLAKI, S; PERRAKI, M; VAMVAKAS, L et al.Annals of oncology. 2007, Vol 18, Num 5, pp 851-858, issn 0923-7534, 8 p.Article

Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancerXENIDIS, N; MARKOS, V; KAKOLYRIS, S et al.Annals of oncology. 2007, Vol 18, Num 10, pp 1623-1631, issn 0923-7534, 9 p.Article

Native valve Aspergillus endocarditis in two patients with aplastic anaemiaPETRIKKOS, G. L; SKIADA, A; SAMONIS, G et al.Scandinavian journal of infectious diseases. 2006, Vol 38, Num 10, pp 916-920, issn 0036-5548, 5 p.Article